PPP4R3A and carcinoma: To examine the cytotoxic effects of sMEK1 and paclitaxel on OVCAR-3 carcinoma cells, cell proliferation was analyzed in the presence of sMEK1 (0.3–1.5 μg) or paclitaxel (5–50 μM).